These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 436537)

  • 41. Treatment of cardiac arrhythmias in dogs with gastric distention-volvulus.
    Muir WW; Bonagura JD
    J Am Vet Med Assoc; 1984 Jun; 184(11):1366-71. PubMed ID: 6735858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Ventricular fibrillation during disopyramide treatment].
    Edhag O; Forssell G; Schenck-Gustafsson K
    Lakartidningen; 1981 Oct; 78(41):3597-600. PubMed ID: 7321703
    [No Abstract]   [Full Text] [Related]  

  • 43. Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.
    Mason JW; Winkle RA
    Circulation; 1978 Dec; 58(6):971-85. PubMed ID: 709781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical studies of Norpace. Summarizing remarks.
    Fowler NO
    Angiology; 1975 Jan; 26(1 Pt 2):154-5. PubMed ID: 1090216
    [No Abstract]   [Full Text] [Related]  

  • 45. Torsade de pointes ventricular tachycardia. A complication of disopyramide shared with quinidine.
    Wald RW; Waxman MB; Colman JM
    J Electrocardiol; 1981 Jul; 14(3):301-7. PubMed ID: 7264507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Wolff-Parkinson-White syndrome. Long-term monitoring for arrhythmias.
    Isaeff DM; Gaston JH; Harrison DC
    JAMA; 1972 Oct; 222(4):449-53. PubMed ID: 4677831
    [No Abstract]   [Full Text] [Related]  

  • 47. Procainamide, disopyramide and quinidine: discordant antiarrhythmic effects during crossover comparison in patients with inducible ventricular tachycardia.
    Wyse DG; Mitchell LB; Duff HJ
    J Am Coll Cardiol; 1987 Apr; 9(4):882-9. PubMed ID: 3558987
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ethyl-3-ethoxycarbonyl-4-hydroxy-2H-1,2-benzothiazine-2-acetate-1,1-dioxide, a compound producing ventricular arrhythmias.
    Pruss TP
    Toxicol Appl Pharmacol; 1969 Jan; 14(1):1-5. PubMed ID: 4180304
    [No Abstract]   [Full Text] [Related]  

  • 49. Lidocaine (Xylocaine) as an anti-arrhythmic agent.
    Med Lett Drugs Ther; 1971 Jan; 13(1):1-2. PubMed ID: 4104507
    [No Abstract]   [Full Text] [Related]  

  • 50. A man with a prolonged episode of palpitations.
    Irwin RS; Weg JG
    Chest; 1996 Nov; 110(5):1351-2. PubMed ID: 8915245
    [No Abstract]   [Full Text] [Related]  

  • 51. [The Wolff-Parkinson-White syndrome. Contribution to the therapeutic study].
    Timio M
    Minerva Cardioangiol; 1967 Dec; 15(12):866-71. PubMed ID: 5610490
    [No Abstract]   [Full Text] [Related]  

  • 52. Ventricular tachycardia-flutter associated with disopyramide therapy: a report of three cases.
    Dhurandhar RW; Nademanee K; Goldman AM
    Heart Lung; 1978; 7(5):783-7. PubMed ID: 250503
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extreme tachycardia complicating the use of disopyramide in atrial flutter.
    Robertson CE; Miller HC
    Br Heart J; 1980 Nov; 44(5):602-3. PubMed ID: 7437205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Wolff-Parkinson-White syndrome and verapamil: apropos of a case of ventricular fibrillation].
    Michel B; Goy JJ; Kappenberger L
    Schweiz Med Wochenschr; 1989 May; 119(19):630-4. PubMed ID: 2740877
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide.
    Keren A; Tzivoni D; Gottlieb S; Benhorin J; Stern S
    Chest; 1982 Mar; 81(3):384-6. PubMed ID: 7056119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation.
    Boriani G; Biffi M; Frabetti L; Azzolini U; Sabbatani P; Bronzetti G; Capucci A; Magnani B
    Am Heart J; 1996 Jun; 131(6):1214-6. PubMed ID: 8644602
    [No Abstract]   [Full Text] [Related]  

  • 57. [Wolff-Parkinson-White syndrome and paroxysmal tachycardia in infancy. Case report and review of literature].
    Pilotti G; Ricci C
    Minerva Pediatr; 1974 Mar; 26(8):426-44. PubMed ID: 4597681
    [No Abstract]   [Full Text] [Related]  

  • 58. Quinidine effects due to disopyramide.
    Frieden J
    N Engl J Med; 1978 Apr; 298(17):975. PubMed ID: 642984
    [No Abstract]   [Full Text] [Related]  

  • 59. Ventricular fibrillation in type B Wolff-Parkinson-White syndrome.
    Lim CH; Toh CC; Chia BL
    Aust N Z J Med; 1974 Oct; 4(5):515-7. PubMed ID: 4532921
    [No Abstract]   [Full Text] [Related]  

  • 60. [Use of ajmaline in the therapy of various heart arrhythmias and comparison with the classic antiarrhythmic drug quinidine].
    Scardino R; Colao G; Didonato F; Sepe V
    Minerva Med; 1970 Sep; 61(78):4289-300. PubMed ID: 4930956
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.